TY - JOUR
T1 - New biomarkers for intervention in breast cancer
AU - Perez, Edith
PY - 2011/5/1
Y1 - 2011/5/1
N2 - The annual San Antonio Breast Cancer Symposium (SABCS) remains one of the most important meetings in the field of breast cancer. SABCS is a forum to present relevant information, combining discussions and presentations in the setting of basic research, translational research, and clinical cancer research. Many of these studies impact patient management and guide the development of new research strategies. The 2010 SABCS was very well attended by investigators, clinicians, and allied health professionals from multiple countries. Presentations at the meeting addressed specific topics, including prevention, management of patients in the early and advanced stage settings, and utilization of molecular markers for research strategies. There were many areas that disclosed important information for clinicians and patients. The abstracts included in this supplement concentrate on advancements in the management of breast cancer patients with both early-stage and advanced-stage disease.
AB - The annual San Antonio Breast Cancer Symposium (SABCS) remains one of the most important meetings in the field of breast cancer. SABCS is a forum to present relevant information, combining discussions and presentations in the setting of basic research, translational research, and clinical cancer research. Many of these studies impact patient management and guide the development of new research strategies. The 2010 SABCS was very well attended by investigators, clinicians, and allied health professionals from multiple countries. Presentations at the meeting addressed specific topics, including prevention, management of patients in the early and advanced stage settings, and utilization of molecular markers for research strategies. There were many areas that disclosed important information for clinicians and patients. The abstracts included in this supplement concentrate on advancements in the management of breast cancer patients with both early-stage and advanced-stage disease.
UR - http://www.scopus.com/inward/record.url?scp=79959753187&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79959753187&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:79959753187
SN - 1543-0790
VL - 9
JO - Clinical Advances in Hematology and Oncology
JF - Clinical Advances in Hematology and Oncology
IS - 5
ER -